Clarius Group LLC’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.2K | Hold |
53,551
| – | – | ﹤0.01% | 479 |
|
|
2025
Q1 | $15.3K | Hold |
53,551
| – | – | ﹤0.01% | 482 |
|
|
2024
Q4 | $31.4K | Hold |
53,551
| – | – | ﹤0.01% | 451 |
|
|
2024
Q3 | $23.9K | Hold |
53,551
| – | – | ﹤0.01% | 453 |
|
|
2024
Q2 | $142K | Hold |
53,551
| – | – | 0.01% | 429 |
|
|
2024
Q1 | $147K | Hold |
53,551
| – | – | 0.01% | 465 |
|
|
2023
Q4 | $130K | Buy |
53,551
+14,124
| +36% | +$34.3K | 0.01% | 466 |
|
|
2023
Q3 | $79.6K | Buy |
+39,427
| New | +$79.6K | 0.01% | 450 |
|
|
2023
Q2 | – | Sell |
-38,000
| Closed | -$95K | – | 494 |
|
|
2023
Q1 | $95K | Buy |
38,000
+5,175
| +16% | +$12.9K | 0.01% | 495 |
|
|
2022
Q4 | $104K | Hold |
32,825
| – | – | 0.01% | 497 |
|
|
2022
Q3 | $97K | Hold |
32,825
| – | – | 0.01% | 476 |
|
|
2022
Q2 | $100K | Sell |
32,825
-242
| -0.7% | -$737 | 0.01% | 458 |
|
|
2022
Q1 | $431K | Hold |
33,067
| – | – | 0.03% | 275 |
|
|
2021
Q4 | $431K | Buy |
33,067
+1
| +0% | +$13 | 0.03% | 275 |
|
|
2021
Q3 | $310K | Buy |
33,066
+241
| +0.7% | +$2.26K | 0.03% | 310 |
|
|
2021
Q2 | $336K | Hold |
32,825
| – | – | 0.03% | 290 |
|
|
2021
Q1 | $604K | Buy |
+32,825
| New | +$604K | 0.06% | 159 |
|